Terms: = Liver cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Diagnosis
23 results:
1. Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and ezh2 and stromal and inflammatory components.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2023 Aug; 83(2):298-309. PubMed ID: 37140546
[TBL] [Abstract] [Full Text] [Related]
2. lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation.
Lin XH; Zhang DY; Liu ZY; Tang WQ; Chen RX; Li DP; Weng S; Dong L
J Transl Med; 2022 Aug; 20(1):379. PubMed ID: 36038907
[TBL] [Abstract] [Full Text] [Related]
3. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
4. Multimodal Imaging under Artificial Intelligence Algorithm for the diagnosis of liver cancer and Its Relationship with Expressions of ezh2 and p57.
Zhang Y; Cui J; Wan W; Liu J
Comput Intell Neurosci; 2022; 2022():4081654. PubMed ID: 35321452
[TBL] [Abstract] [Full Text] [Related]
5. A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients.
Liu Y; Liu X; Gu Y; Lu H
Medicine (Baltimore); 2021 Jul; 100(29):e26491. PubMed ID: 34398005
[TBL] [Abstract] [Full Text] [Related]
6. Circ_ 0115744 acts as miR-144 sponge to promote and predict the metastasis of colorectal cancer.
Ma X; Lv L; Xing C
Aging (Albany NY); 2021 Feb; 13(4):5892-5905. PubMed ID: 33591945
[TBL] [Abstract] [Full Text] [Related]
7. Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma.
Li B; Li A; You Z; Xu J; Zhu S
Cell Death Dis; 2020 Oct; 11(10):823. PubMed ID: 33009370
[TBL] [Abstract] [Full Text] [Related]
8. LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting ezh2-regulated RECK.
Zhang G; Chen X; Ma L; Ding R; Zhao L; Ma F; Deng X
Aging (Albany NY); 2020 Jun; 12(11):11071-11084. PubMed ID: 32522890
[TBL] [Abstract] [Full Text] [Related]
9. LINC00978 promotes the progression of hepatocellular carcinoma by regulating ezh2-mediated silencing of p21 and E-cadherin expression.
Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
[TBL] [Abstract] [Full Text] [Related]
10. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting ezh2-regulated EPHA7.
Di W; Weinan X; Xin L; Zhiwei Y; Xinyue G; Jinxue T; Mingqi L
Cell Death Dis; 2019 Jul; 10(7):514. PubMed ID: 31273190
[TBL] [Abstract] [Full Text] [Related]
11. Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma.
Xiang XH; Yang L; Zhang X; Ma XH; Miao RC; Gu JX; Fu YN; Yao Q; Zhang JY; Liu C; Lin T; Qu K
World J Gastroenterol; 2019 Apr; 25(14):1715-1728. PubMed ID: 31011256
[TBL] [Abstract] [Full Text] [Related]
12. [SCCOHT/ovarian rhabdoid tumor: A case report].
Bourgoin R; Cornelis F; Masliah-Planchon J; Genestie C; Laé M
Ann Pathol; 2019 Sep; 39(5):357-363. PubMed ID: 30928254
[TBL] [Abstract] [Full Text] [Related]
13. Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through ezh2-mediated ATOH8 transcriptional repression.
Zhang Y; Tang B; Song J; Yu S; Li Y; Su H; He S
J Exp Clin Cancer Res; 2019 Feb; 38(1):92. PubMed ID: 30786928
[TBL] [Abstract] [Full Text] [Related]
14. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic liver Disease Justified? A Systematic Review and Meta-Analysis.
Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
[TBL] [Abstract] [Full Text] [Related]
15. The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma.
Sanna L; Marchesi I; Melone MAB; Bagella L
J Cell Physiol; 2018 Sep; 233(9):6508-6517. PubMed ID: 29574790
[TBL] [Abstract] [Full Text] [Related]
16. From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma.
Vasuri F; Malvi D; Bonora S; Fittipaldi S; Renzulli M; Tovoli F; Golfieri R; Bolondi L; D'Errico A
Histopathology; 2018 Feb; 72(3):414-422. PubMed ID: 28881044
[TBL] [Abstract] [Full Text] [Related]
17. Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study.
Brown RE; Buryanek J; McGuire MF
Ann Clin Lab Sci; 2017 Aug; 47(4):457-465. PubMed ID: 28801373
[TBL] [Abstract] [Full Text] [Related]
18. Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications.
Sciarra A; Di Tommaso L; Nakano M; Destro A; Torzilli G; Donadon M; Maggioni M; Bosari S; Bulfamante G; Matsuda M; Fujii H; Ichikawa T; Morisaka H; Sano K; Ichikawa S; Roncalli M
J Hepatol; 2016 Jan; 64(1):87-93. PubMed ID: 26343958
[TBL] [Abstract] [Full Text] [Related]
19. Immunostaining for polycomb group protein ezh2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract] [Full Text] [Related]
20. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract] [Full Text] [Related]
[Next]
